Mark A Micek
Overview
Explore the profile of Mark A Micek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wagenaar B, Gimbel S, Hoek R, Pfeiffer J, Michel C, Cuembelo F, et al.
Glob Health Action
. 2016 Sep;
9:31980.
PMID: 27580822
Background: We describe wait and consult times across public-sector clinics and identify health facility determinants of wait and consult times. Design: We observed 8,102 patient arrivals and departures from clinical...
12.
Dross S, Rossi S, Beck I, Micek M, Blanco A, Seidel K, et al.
AIDS
. 2014 Sep;
28(16):2491-3.
PMID: 25265235
No abstract available.
13.
Micek M, Dross S, Blanco A, Beck I, Matunha L, Seidel K, et al.
J Infect Dis
. 2014 Mar;
210(4):641-5.
PMID: 24596282
Acquisition of nevirapine (NVP)-resistant human immunodeficiency virus type 1 (HIV-1) by breast-feeding infants after receipt of single-dose NVP to prevent mother-to-child transmission is not well defined. A prospective observational study...
14.
Mitchell C, Dross S, Beck I, Micek M, Frenkel L
Clin Infect Dis
. 2014 Feb;
58(8):1190-3.
PMID: 24501389
Among infants exposed to human immunodeficiency virus type 1 (HIV-1), detection of viral infection at birth was increased by 39% (95% confidence interval, 19%-47%) by increasing DNA input from dried...
15.
Creswell J, Codlin A, Andre E, Micek M, Bedru A, Carter E, et al.
BMC Infect Dis
. 2014 Jan;
14:2.
PMID: 24383553
Background: The Xpert MTB/RIF assay has garnered significant interest as a sensitive and rapid diagnostic tool to improve detection of sensitive and drug resistant tuberculosis. However, most existing literature has...
16.
Gerdts S, Wagenaar B, Micek M, Farquhar C, Kariaganis M, Amos J, et al.
J Acquir Immune Defic Syndr
. 2013 Dec;
66(2):e37-44.
PMID: 24326605
Background: Access to antiretroviral therapy (ART) has increased dramatically in resource-limited settings since its introduction a decade ago. However, ART coverage remains low in countries with the highest disease burden,...
17.
Furukawa N, Mendoza-Ticona A, Alarcon-Villaverde J, Montejo H, Micek M, Zunt J
Eur Respir J
. 2013 Dec;
43(4):1192-5.
PMID: 24311774
No abstract available.
18.
Gantt S, Payant R, Carlsson J, Micek M, Blanco A, Beck I, et al.
J Pediatric Infect Dis Soc
. 2013 May;
1(3):244-9.
PMID: 23687579
Among 30 human immunodeficiency virus type 1 (HIV-1)-infected women who received single-dose nevirapine (NVP), 17 (57%) had NVP-resistant HIV-1 detected in breast milk. NVP resistance in breast milk persisted for...
19.
Lambdin B, Micek M, Sherr K, Gimbel S, Karagianis M, Lara J, et al.
J Acquir Immune Defic Syndr
. 2013 Jan;
62(5):e146-52.
PMID: 23288031
Background: In 2004, the Mozambican Ministry of Health began a national scale-up of antiretroviral therapy (ART) using a vertical model of HIV clinics colocated within large urban hospitals. In 2006,...
20.
Micek M, Blanco A, Carlsson J, Beck I, Dross S, Matunha L, et al.
J Infect Dis
. 2012 Apr;
205(12):1811-5.
PMID: 22492850
Single-dose nevirapine (sdNVP) given to prevent mother-to-child-transmission of HIV-1 selects NVP-resistance. Short-course zidovudine (ZDV) was hypothesized to lower rates of NVP-resistance. HIV-1 infected pregnant women administered sdNVP with or without...